D.E. Shaw & Co
LHDX

D.E. Shaw & Co’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

D.E. Shaw & Co’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,866
Closed -$26K – 5752
2022
Q2 		$26K Sell
13,866
-5,782
-29% -$14.1K ﹤0.01% 4965
2022
Q1 		$70K Sell
19,648
-54,917
-74% -$270K ﹤0.01% 5067
2021
Q4 		$642K Buy
+74,565
New +$474K ﹤0.01% 4257

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $867M AUM 16.97% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $342M AUM 17.59% 1-Year Est. Return